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OBJECTIVE—The signiﬁcant roles of brown adipose tissue
(BAT) in the regulation of energy expenditure and adiposity are
established in small rodents but have been controversial in
humans. The objective is to examine the prevalence of metabol-
ically active BAT in healthy adult humans and to clarify the
effects of cold exposure and adiposity.
RESEARCH DESIGN AND METHODS—In vivo 2-[
18F]ﬂuoro-
2-deoxyglucose (FDG) uptake into adipose tissue was measured
in 56 healthy volunteers (31 male and 25 female subjects) aged
23–65 years by positron emission tomography (PET) combined
with X-ray computed tomography (CT).
RESULTS—When exposed to cold (19°C) for 2 h, 17 of 32
younger subjects (aged 23–35 years) and 2 of 24 elderly subjects
(aged 38–65 years) showed a substantial FDG uptake into
adipose tissue of the supraclavicular and paraspinal regions,
whereas they showed no detectable uptake when kept warm
(27°C). Histological examinations conﬁrmed the presence of
brown adipocytes in these regions. The cold-activated FDG
uptake was increased in winter compared with summer (P 
0.001) and was inversely related to BMI (P  0.001) and total
(P  0.01) and visceral (P  0.001) fat areas estimated from CT
image at the umbilical level.
CONCLUSIONS—Our ﬁndings, being against the conventional
view, indicate the high incidence of metabolically active BAT in
adult humans and suggest a role in the control of body temper-
ature and adiposity. Diabetes 58:1526–1531, 2009
M
ammals have two types of adipose tissue,
white (WAT) and brown (BAT) adipose tis-
sues. These two tissues have quite opposite
roles in whole-body energy metabolism; that
is, WAT is for energy storage and BAT is for cold- and
diet-induced thermogenesis, which signiﬁcantly contrib-
utes to the control of body temperature and energy
expenditure (1). BAT thermogenesis is principally depen-
dent on the -adrenergically mediated activation of li-
polysis and subsequent degradation of fatty acids via
uncoupling protein 1 (UCP1), which uncouples mitochon-
drial oxidative phosphorylation to dissipate the electro-
chemical gradient as heat instead of ATP synthesis. Thus,
the -adrenoceptor–UCP1 system has been expected as an
intriguing target for the control of whole-body energy
balance, adiposity, and obesity (2–5).
Almost all views about BAT thermogenesis have come
from studies using small rodents such as the mouse, rat,
and hamster. In humans, signiﬁcant amounts of BAT are
present in newborns and may contribute to body temper-
ature regulation during the neonatal period, probably in
the same way as in small rodents. However, BAT seems to
disappear rapidly during postnatal periods and in adults
is rather difﬁcult to identify by conventional anatomical
examinations. Thus, it has been a general contention that
BAT is absent or of minute amounts and plays negligible,
if any, roles in adult humans (6–8).
The existence of metabolically active BAT in adult
humans has been suggested by the current clinical studies
using ﬂuoro-deoxyglucose (FDG)–positron emission to-
mography (PET), one of the powerful diagnostic tools for
malignant tumors; that is, PET sometimes detects symmet-
rical FDG uptake in the shoulder and thoracic spine
regions, where no tumor is present. By simultaneous
examinations with PET and X-ray computed tomography
(CT), the site of FDG uptake was identiﬁed as adipose
tissue (9). Such FDG uptake is increased at lower environ-
mental temperatures (10–12) and reduced by pretreatment
with -adrenergic blockers (13,14). These ﬁndings collec-
tively suggest that the FDG uptake in adipose tissue at the
speciﬁc regions reﬂects the metabolic activity of BAT (15).
However, almost all human studies thus far reported
seemed for more accurate diagnosis of cancer and not for
the detection and evaluation of BAT itself. In this study,
we performed FDG-PET/CT examinations in adult healthy
volunteers under a warm and cold condition to clarify the
effects of cold exposure, age, season, and other body
parameters including body fat. Our data indicate an unex-
pected high incidence of cold-activated BAT in adult
healthy humans and suggest a role in the regulation of
metabolic thermogenesis and body fat content.
RESEARCH DESIGN AND METHODS
Subjects recruited for this study were 56 healthy volunteers (31 male and 25
female subjects) aged 23–65 years (Table 1). All subjects were carefully
instructed about the study and gave their informed consent to participate.
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1526 DIABETES, VOL. 58, JULY 2009After a standardized health examination, they underwent FDG-PET/CT and
other examinations once or twice from August of 2006 to the following March.
The protocol was approved by the institutional review boards of Tenshi
College.
FDG-PET/CT. After fasting for 6–12 h, the subjects were kept in an
air-conditioned room at 19°C with light clothing (usually a T-shirt with
underwear) and put their legs on an ice block intermittently (usually for 4 min
every 5 min). After 1 h under this cold condition, they were given an
intravenous injection of
18F-ﬂuoro-2-deoxyglucose (FDG) (259 MBq) and kept
under the same cold condition. In some cases, the subjects were kept at
26–28°C with standard clothing and without leg icing (warm condition). One
hour after the
18F-FDG injection, whole-body PET/CT scans were performed
on a PET/CT system (Aquiduo; Toshiba Medical Systems, Otawara, Tochigi,
Japan) in a room at 24°C. With the CT parameters of 120 kv and real-exposure
control, unenhanced low-dose spiral axial 2-mm collimated images were
obtained. This was used for PET attenuation correction as well as anatomic
localization. Subsequently, full-ring PET was performed in six incremental
table positions, each 15 cm in thickness. The total time of these scans was
30 min.
PET and CT images were coregistered and analyzed by a VOX-BASE
workstation (J-MAC System, Sapporo, Japan). Two experienced blinded
observers assessed the FDG uptake, particularly in both sides of the neck and
paravertebral regions, by visually judging the radioactivity greater than
background. In parallel, the FDG uptake in the neck region was quantiﬁed and
expressed as relative to that in the whole brain.
Anthropometric and body fat measurement and blood analysis. BMI was
calculated as body weight in kilograms divided by the square of height in
meters (kg/m
2), and percent of body fat was estimated by the multifrequency
bioelectric impedance method (InBody 320 Boy Composition Analyzer; Bio-
space, Seoul, Korea). The abdominal and subcutaneous fat areas at the level
of L4–L5 were estimated from the CT images. Serum levels of leptin and
adiponectin were measured using respective enzyme-linked immunosorbent
assay (ELISA) kits (Human leptin ELISA kit, B-Bridge, Mountain View, CA;
Human adiponectin ELISA kit, Otsuka Pharmaceutical, Tokyo, Japan). Other
blood parameters were analyzed by a company of laboratory testing services
(SRL, Tokyo, Japan).
Histological examinations. An autopsy tissue specimen was obtained from
fat depots of the supraclavicular region of a 21-year-old man and stained with
hematoxylin-eosin or an anti-serum against rat UCP1 (16).
Data analysis. Data are expressed as means  SD and analyzed by paired or
Student’s t test. 
2 test was used for the data of the prevalence of BAT. SPSS
softwear package (version 10.0; Chicago, IL) was used for correlation analysis
between BAT and adiposity-related parameters.
RESULTS
Since one of the typical methods to activate BAT in
rodents is cold exposure, we ﬁrst examined the acute
effects of cold exposure on FDG uptake. For this, healthy
subjects were overnight fasted and kept in a room at 28°C
(warm condition) or at 19°C with light clothes and inter-
mittent application of an ice-cooled footrest (cold condi-
tion). Two hours later, they underwent FDG-PET/CT
examination. Under the warm condition, a clear FDG
uptake was detected in the brain, heart, and the oro-
pharengeal region, while no FDG signal in adipose tissue
(Fig. 1B). When the same subjects were kept under the 2-h
cold condition, a clear and intense FDG uptake was found
in adipose tissue at the supraclavicular and paraspinal
regions (Fig. 1A).
During a 7-month period from August of 2006 to the
following March, we performed a total of 71 FDG-PET/CT
examinations under the 2-h cold condition for 56 healthy
volunteers aged 23–65 years. As summarized in Table 2,
cold-activated FDG uptake in the supraclavicular region
was detected in 18 of 55 subjects (33%) in winter from
January to March. Although the incidence of such FDG
uptake seemed not to show apparent sex difference, it
changed with age (P  0.01 by 
2 test), being 52% (16 of 31)
and 8% (2 of 24) in younger (aged 23–35 years) and elderly
(aged 38–65 years) subjects, respectively. Table 2 conﬁrms
again the stimulatory effect of acute cold exposure on FDG
uptake as typically shown in Fig. 1; that is, eight subjects who
showed clear FDG uptake under the cold condition were
tested again under the warm condition at 28°C in 2 weeks,
but none of them showed detectable FDG uptake in the
adipose tissue, including supraclavicular and paraspinal re-
gions, regardless of the test seasons.
Table 2 also suggests some seasonal variations of the
total prevalence, being low in summer from August to
September. This was clearly demonstrated from the re-
sults of some individual subjects; that is, in summer, the
FDG uptake was detected in two of eight subjects. When
the same subjects were examined again in winter, it was
found in six subjects, four of which showed no FDG
uptake in summer and the other two showed lower uptake
in summer (Fig. 2B). Moreover, FDG uptake was some-
times detected both at the supraclavicular and paraspinal
regions in winter but only in the supraclalvicular region in
summer (Fig. 2A). Thus, the incidence and intensity of
cold-activated FDG uptake showed seasonal variations,
being higher in winter.
In small rodents, BAT thermogenesis is recognized as a
signiﬁcant component of whole-body energy expenditure
and thereby contributes to the regulation of body fat
TABLE 1
Subject proﬁles
Male subjects Female subjects
n 31 25
Age (years) 35.8  9.0 (23–65) 38.8  8.8 (25–65)
Height (cm) 170.7  5.2 (154–181) 158.0  4.4 (148–166)
Body weight (kg) 68.8  7.6 (53.2–91.0) 52.5  5.4 (40.6–63.4)
BMI (kg/m
2) 23.8  2.6 (17.7–31.0) 21.1  2.3 (16.2–26.9)
Body fat (kg) 16.4  4.8 (5.7–36.8) 14.9  4.4 (7.4–26.2)
Blood parameters
Glucose (mg/dl) 88.7  5.6 (71–102) 83.4  5.1 (71–96)
A1C (%) 4.8  0.2 (4.5–5.5) 4.8  0.2 (4.0–5.1)
Total cholesterol (mg/dl) 195  21 (115–251) 203  22 (159–272)
HDL cholesterol (ng/dl) 61.6  11.8 (35–90) 73.0  12.0 (51–98)
Triglycerides (mg/dl) 113  57 (19–395) 67  25 (29–183)
Insulin (ng/ml) 4.5  2.5 (1.1–10.4) 3.5  1.3 (1.3–5.3)
Leptin (ng/ml) 5.0  4.1 (0.3–26.1) 11.1  7.1 (1.4–28.6)
Adiponectin (g/ml) 10.3  3.2 (3.9–18.0) 15.1  4.6 (3.3–24.7)
T3 (pg/ml) 2.0  0.6 (1.0–3.7) 1.9  0.8 (0.5–4.4)
Data are means  SD, with minimum and maximum values in parentheses.
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humans, we ﬁrst analyzed the relationship between the
cold-activated FDG uptake into BAT and adiposity in a
total of 19 subjects bearing detectable BAT. As shown in
Fig. 3, FDG uptake into the supraclavicular adipose tissue
showed signiﬁcant inverse relations to BMI (r  0.674,
P  0.001), total fat (r  0.564, P  0.01), and visceral fat
(r  0.681, P  0.001). Weaker but signiﬁcant inverse
relationships were also found to subcutaneous fat (r 
0.492, P  0.05) and plasma insulin level (r  0.473,
P  0.05) but not to plasma levels of leptin, adiponectin,
and T3 (data not shown).
We also compared the similar parameters in subjects
bearing detectable and undetectable amounts of cold-
activated BAT (Table 3). As expected from the results in
Table 2, the mean age was signiﬁcantly lower in the group
bearing detectable BAT than that without BAT. Body
weight, BMI, and visceral and subcutaneous fat areas
estimated from CT tended to be lower in the group bearing
detectable BAT, but the difference was not statistically
signiﬁcant. Since these parameters of adiposity are much
inﬂuenced by aging, being higher in elderly subjects, next,
we compared the two groups of 32 younger subjects (aged
23–35 years) (Table 2). The mean age was comparable in
the two groups (aged 27.3 vs. 29.1 years in male subjects,
aged 30.3 vs. 29.5 years in female subjects); the effects of
aging may be canceled. There was no difference in height,
body weight, and blood parameters examined between the
two groups in both male and female subjects. The group
bearing detectable BAT tended to show decreased BMI, body
fat content, and visceral fat area compared with that without
BAT, but again the difference was not statistically signiﬁcant
(data not shown). In a separate study, we examined histo-
logically an autopsy sample of fat depots obtained from the
supraclavicular region and found numerous multilocular
adipocytes expressing UCP1 protein (Fig. 4).
DISCUSSION
In this study, we performed FDG-PET/CT examination in
adult healthy volunteers, particularly focusing on the
effects of cold exposure and adiposity-related parameters
FIG. 1. Whole-body FDG-PET images under cold or warm condition. A: A 25-year-old male subject fasted for 12 h and was kept in an air-conditioned
room at 19°C with light clothing and put his legs on an ice block intermittently (for 4 min at every 5 min). After 1 h under this cold condition, he was
given an intravenous injection of
18F-FDG and kept under the same cold condition. One hour after the
18F-FDG injection, whole-body PET/CT scans
were performed in a room at 24°C. B: Two weeks after the ﬁrst examination in the cold condition (A), the same subject underwent FDG-PET/CT
examination as previously, but he was kept at 27°C with standard clothing and without leg icing (warm condition) for 2 h before the examination.
TABLE 2
Prevalence of cold-activated BAT in adult humans
Summer Autumn Winter
Outdoor temperature (°C) 21.3 (19.6–28.3) 11.7 (7.6–16.1) 1.6 (5.2 to 1.8)
n 8 8 31 24
Age (years) 23–31 23–32 23–35 38–65
Prevalence
Total 2/8 (0/1) 3/8 (0/3) 16/31 (0/4) 2/24
Male subjects 1/5 2/6 (0/2) 8/19 (0/3) 2/12
Female subjects 1/3 (0/1) 1/2 (0/1) 8/12 (0/1) 0/12
Data are mean outdoor temperature (range) or n apparent FDG uptake into BAT (adipose tissue in the supraclavicular region)/total n. During
a 7-month period from August of 2006 to the following March, a total of 71 FDG-PET/CT examinations were conducted under the 2-h cold
condition for 56 healthy volunteer subjects as in Fig. 1A. Some (the number in parentheses) underwent the examination again under the warm
condition as in Fig. 1B 2 weeks after that under the cold condition. Summer: 29 August to 28 September 2006. Autumn: 5 October to 19
October 2006. Winter: 29 January to 6 March 2007.
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regions, where UCP1-positive brown adipocytes were de-
tected. The major ﬁndings were 1) FDG uptake in adipose
tissue in the supraclavicular and paraspinal regions was
negligible in warm conditions but markedly increased
after a 2-h cold exposure, 2) cold-activated FDG uptake
was increased in winter compared with summer, 3)i tw a s
detected in about half of younger subjects but in much
fewer elderly subjects, and 4) it decreased with increasing
adiposity assessed by BMI and body fat content.
It has been reported in rodents that cold exposure
markedly increased 2-deoxy-D-glucose (2-DG) uptake into
BAT but only slightly into WAT (17–20). The stimulatory
effects of cold exposure were mimicked by electrical
stimulation of sympathetic nerves into BAT and -adren-
ergic agonist administration but were abolished by surgi-
cal severing of the sympathetic nerves or -adrenergic
blockade.
We (21) demonstrated that the -adrenergically stimu-
lated 2-DG uptake into BAT is totally dependent on the
activation of UCP1 and is thereby a metabolic marker of
BAT. Our present ﬁndings of increased FDG uptake into
adipose tissues of the speciﬁc regions after 2-h cold
exposure are quite similar to those in rodents and thus
support the idea that it reﬂects the activation of BAT and
that adult humans have, more or less, metabolically active
BAT. These seem consistent with previous case reports
about patients with malignant lymphoma and some other
types of tumors, where the incidence of FDG uptake in the
supraclavicular region is higher when the examination was
performed at lower room temperatures (10–12).
In our study, cold-activated FDG uptake was markedly
increased when examined in winter compared with sum-
mer. Cohade et al. (10) reported that the incidence of FDG
uptake into the supraclavicular region showed seasonal
variations, being higher from January to March. It is
known in mice and rats that chronic cold exposure (cold
acclimation) results in hyperplasia of BAT and increased
2-DG uptake (1,18–20). Moreover, cold acclimation has
been shown in rodents to induce an apparent transdiffer-
entiation of WAT to BAT (22–24). Considering that the
average outdoor temperature in our study was 1.6°C in
winter and 21.3°C in summer, it is quite likely that the
increased FDG uptake in winter is attributable to hyper-
plasia of BAT and/or transdifferentiation of WAT to BAT.
Collectively, it can be concluded that the cold-activated
FDG uptake in the supraclavicular and paraspinal regions
is an index of the amount and activity of BAT.
FIG. 2. FDG uptake into BAT in summer and winter. A: A 30-year-old female subject underwent FDG-PET/CT examination under the cold
condition as in Fig. 1 on 29 August 2006 (summer) and again on 22 February 2007 (winter). B: Eight subjects (ﬁve male and three female subjects)
underwent FDG-PET/CT examination under the cold condition in summer (29 August to 28 September 2006) and again in winter (29 January to
6 March 2007). FDG uptake into the supraclavicular region was densitometrically quantiﬁed, normalized, and expressed as relative to that in the
brain. Thick bars are means  SD.
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FIG. 3. Cold-activated BAT and adiposity. Cold-activated FDG uptake into the supraclavicular region of 19 subjects was quantiﬁed as in Fig. 2
and plotted against BMI and total and visceral fat areas estimated from CT images at the umbilical (L4 and L5) level.
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years) subjects have metabolically active BAT, being quite
against the widely accepted view that the amount and
activity of BAT are negligible in adult humans. Although
the prevalence of BAT was much decreased in elderly
subjects (aged 38–65 years), the prevalence in our study is
much higher than those previously reported in clinical
studies (10), where FDG uptake in the shoulder region is
detected in some patients (10%) at relatively low room
temperatures (22°C) but not found at higher tempera-
tures (	25°C). The reason for the high prevalence in our
study must be that our subjects were kept at a lower
temperature (19°C) and stimulated by intermittent ice
cooling of legs. In other words, our condition of cold
exposure may be more appropriate to detect BAT. More
interesting in our results is the relationship between BAT
and adiposity of the subjects; that is, cold-activated FDG
uptake into BAT showed signiﬁcant inverse relations to
BMI, body fat, and visceral fat. Weaker but signiﬁcant
inverse relations were also found to subcutaneous fat and
plasma insulin level.
This seems quite compatible with the observation in
rodents that the amount and activity of BAT is decreased
in obesity. There is ample evidence that BAT thermogen-
esis is a signiﬁcant component of whole-body energy
expenditure and thereby contributes to the regulation of
energy balance and body fat content (1). Our present
results thus imply a signiﬁcant role of BAT in the control
of adiposity via the regulation of energy expenditure in
humans in the same way as in rodents. Being consistent
with this idea, the subjects bearing detectable BAT tended
to be low in BMI and body fat content compared with
those without BAT, although the difference did not reach
statistically signiﬁcant levels.
Another point to be noted is that the incidence of
cold-activated BAT decreased in elderly subjects. In a total
of 24 elderly subjects, BAT was detected in only 2 male
subjects (Table 2). It is interesting that these 2 male
subjects are rather lean, with BMI 22.2 and 20.6 kg/m
2,
respectively, compared with the other 10 male subjects
bearing no BAT with BMI of 24.4 kg/m
2. Although these
results are preliminary and are yet to be conﬁrmed in
larger numbers of subjects, they may imply that the
disappearance of BAT accelerates the development of
obesity with aging. This idea seems consistent with our
previous observation that UCP1 deﬁciency in mice in-
creases susceptibility to diet-induced obesity with age
(25).
The present results thus collectively suggest that cold-
activated BAT participates, more or less, in the control of
energy expenditure and adiposity in humans, as it does in
small rodents. This may require reevaluation of the phys-
iological relevance of BAT in humans. For example, it is
not rare that experimentally and/or clinically estimated
basal metabolic rate, as well as postprandial thermo-
genesis (diet-induced thermogenesis), varies considerably
among individuals even after correcting possible contrib-
uting factors such as sex, age, and body dimensions. It may
be possible that such variations are due to the individual
differences in BAT activity. Moreover, our results may
highlight again a pharmacological approach to obesity
treatment, which has repeatedly been conﬁrmed in exper-
imental animals (3,4,26,27) but not yet approved in hu-
mans; that is, agonists speciﬁc to the 3-adrenergic
receptor effectively reduce adiposity in small rodents and
dogs but to a much lesser extent in humans. Based on our
results, it may be likely that 3-adrenergic agonists are
effective only for individuals who keep active BAT, as in
wild-type but not UCP1-deﬁcient mice (4). Our present
ﬁndings suggest revisiting such intriguing subjects.
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FIG. 4. Histological identiﬁcation of UCP1-positive brown adipocytes
in fat depots obtained from the supraclavicular region. Tissue sections
were stained with hematoxylin and eosin (A) or anti-serum against rat
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the online issue.)
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